Zhang et al. [23] studied the antitumor effects of HBG and ABG on estrogen receptor (ER)-positive breast cancer cell line MCF-7 and triple-negative breast cancer cell line MDA-MB-231. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.